Opendata, web and dolomites

GABARPET SIGNED

ImmunoPET directed to specific subtypes of GABAA receptors as strategy for molecular mapping of behaviour and mental illness

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GABARPET project word cloud

Explore the words cloud of the GABARPET project. It provides you a very rough idea of what is the project "GABARPET" about.

tracers    scfv    invasive    individuals    postmortem    molecular    intact    mice    affinity    light    antibodies    unveil    clear    single    brain    wild    phenotype    alpha    neurological    tomography    gabarpet    di    conventional    labeled    healthy    knockout    quantitative    antibody    pet    limited    diseases    imaging    cyclotron    directed    wants    vivo    chain    surface    gaba    effect    readily    changes    small    sensitive    penetrate    rodent    cell    radionuclides    setting    barrier    shed    injection    emission    reveals    18f    mostly    89zr    characterization    lack    fragment    construct    disorder    society    expression    schizophrenia    transferrin    sense    differential    transmigrate    suggested    subunits    psychiatric    tap    blood    receptors    positron    immunopet    recombinant    gabaergic    hallmarks    bbb    peripheral    additional    mental    nevertheless    diagnosis    reveal    specificity    patients    severe    receptor    biomarkers    probes    insights    models    abnormalities    papers    disease    profound    immune    gabaa    neuroimage    bispecific   

Project "GABARPET" data sheet

The following table provides information about the project.

Coordinator
TURUN YLIOPISTO 

Organization address
address: YLIOPISTONMAKI
city: Turku
postcode: 20014
website: www.utu.fi

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 304˙021 €
 EC max contribution 304˙021 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-CAR
 Starting year 2020
 Duration (year-month-day) from 2020-09-01   to  2023-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TURUN YLIOPISTO FI (Turku) coordinator 304˙021.00

Map

 Project objective

Changes in GABA receptors are known hallmarks for numerous neurological diseases including schizophrenia which is a severe psychiatric disorder that has a profound effect on both the individuals affected and society. The diagnosis of schizophrenia is complex because of the loss of high specific biomarkers. Research papers have suggested that the differential expression of GABAA receptors in the brain is associated with this mental disease. The current evidence on GABAergic abnormalities in schizophrenia is mostly based on postmortem studies and, in this sense, in vivo measurements of GABAA receptor subunits can reveal additional insights. This project will develop Positron Emission Tomography (PET) probes which could unveil quantitative information about GABAA receptor expression in schizophrenia patients. However, the lack of imaging tracers with high affinity and specificity do not shed a clear light on the diagnosis in a traditional PET setting. In this sense, the immune-positron emission tomography (immunoPET) is a non-invasive technology based in antibody imaging which reveals a specific and sensitive molecular characterization of the cell surface phenotype in vivo. Nevertheless, its success in neuroimage is limited because of intact antibodies cannot penetrate the Brain Blood Barrier (BBB) in healthy conditions. However, GABARPET will tap into a small recombinant bispecific antibody construct targeting the GABAA receptors as well as the transferrin receptor because it is able to readily transmigrate across the BBB in vivo after peripheral injection. This project wants to develop di-single-chain variable fragment (di-scFv) directed to α1 and α2 subunits of GABAA receptors. Then, they will be labeled with conventional radionuclides produced by cyclotron as 18F and 89Zr. ImmunoPET probes will be used in wild-type mice, GABAA receptor knockout mice and different kind of rodent models of schizophrenia.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GABARPET" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GABARPET" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

HSQG (2020)

Higher Spin Quantum Gravity: Lagrangian Formulations for Higher Spin Gravity and Their Applications

Read More  

CREDit (2020)

Chronological REference Datasets and Sites (CREDit) towards improved accuracy and precision in luminescence-based chronologies

Read More  

DEF2DEV (2019)

Identification of the mode of action of plant defensins during root development and plant defense responses.

Read More